Carbamazepine Tablet, Extended Release
Product Images NDC 0832-6022

4 FDA label images from Upsher-smith Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 0832-6022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carbamazepine 01)

Chemical Structure (Carbamazepine 01)
Chemical structure diagram of the active ingredient carbamazepine. The structure shows a tricyclic compound with an amide group attached, consistent with carbamazepine's molecular configuration as depicted on the product's labeling.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
Label for Carbamazepine Extended-Release Tablets, USP 100 mg from Upsher-Smith Laboratories, LLC. The label shows dosage form as extended-release tablets, package count of 100 tablets, and includes storage instructions, manufacturer and distributor info, barcode, and precautionary notes on tablet use and child-resistant packaging.*
FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Principal Display Panel (200 mg Tablet Bottle Label)
Label for Carbamazepine Extended-Release Tablets USP 200 mg, showing 100 tablets in the package. The label includes dosage form as extended-release oral tablets, manufacturer Upsher-Smith Laboratories, LLC, and storage instructions. It also warns that tablets must be swallowed whole and not crushed or chewed. Barcode and regulatory symbols are visible.*
FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Principal Display Panel (400 mg Tablet Bottle Label)
Label for Carbamazepine Extended-Release Tablets, USP, 400 mg oral tablets. The package contains 100 tablets and is labeled for prescription use only. Manufactured by CSPC Ouyi Pharmaceutical Co., Ltd and distributed by Upsher-Smith Laboratories, LLC. The label includes storage instructions and a note that tablets must be swallowed whole and not crushed or chewed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.